Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment

scientific article published on December 2005

Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P932PMC publication ID2497370
P698PubMed publication ID25696443

P2093author name stringF J Ten Cate
M L Geleijnse
C van der Lee
M J Kofflard
P2860cites workMutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleQ24324826
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathyQ28236892
Sudden death due to troponin T mutationsQ28305351
Prognosis and mortality of hypertrophic obstructive cardiomyopathyQ33170393
Molecular genetics and pathogenesis of hypertrophic cardiomyopathyQ34021080
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) AdultsQ34058337
Hypertrophic cardiomyopathy: a systematic reviewQ34117625
New insights into the pathology of inherited cardiomyopathyQ35583633
Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affairQ35679277
Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I geneQ35938322
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosisQ36782521
Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathyQ36915274
Recent Advances in the Molecular Genetics of Hypertrophic CardiomyopathyQ40467490
Molecular basis of familial cardiomyopathiesQ40559439
Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathyQ40599706
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathyQ47879338
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathyQ47879851
Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C geneQ47957734
Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathyQ48020405
Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patientsQ67019025
Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophyQ68860551
The natural (and unnatural) history of hypertrophic obstructive cardiomyopathyQ70048652
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathyQ70658788
Prognosis in hypertrophic cardiomyopathyQ70795347
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patientsQ71827470
Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathyQ72773598
Apical hypertrophic cardiomyopathy developing at a relatively advanced ageQ73635743
Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletesQ74315525
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T diseaseQ74522881
Functional obstruction of the left ventricle; acquired aortic subvalvar stenosisQ74682836
AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathyQ77580246
The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the NetherlandsQ79175295
Hypertrophic cardiomyopathyQ80172333
P433issue12
P921main subjecthypertrophic cardiomyopathyQ1364270
P304page(s)452-460
P577publication date2005-12-01
P1433published inNetherlands Heart JournalQ2146163
P1476titleHypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment
P478volume13